Medindia

X

Avastin , the Cancer Drug Brings Hope as a Cost-effective Treatment for AMD

by Savitha C Muppala on  April 30, 2011 at 2:17 AM Drug News   - G J E 4
A recent study compared the performance of Avastin, a cancer treatment drug and Ludentis, a drug used to treat a degenerative eye disease, which showed that both drugs performed with the same level of efficiency in treating age-related macular degeneration.  
 Avastin , the Cancer Drug Brings Hope as a Cost-effective Treatment for AMD
Avastin , the Cancer Drug Brings Hope as a Cost-effective Treatment for AMD
Advertisement

Patients who received monthly doses of Avastin were benefitted by a 8.0 letters of visual acuity as compared to an 8.5 letter improvement produced by the drug Ludentis.

Advertisement
Both drugs are manufactured by the same company, Genentech, but are differently priced.

While a single dose of Avastin costs about $50, patients will have to cough up so much more for a single dose of Ludentis, priced at about $2,000.



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All